博士論文

Gefitinib ('Iressa', ZD1839), an EGFR tyrosine kinase inhibitor, reverses breast cancer resistance protein (BCRP/ABCG2) -mediated drug resistance

Icons representing 博士論文

Gefitinib ('Iressa', ZD1839), an EGFR tyrosine kinase inhibitor, reverses breast cancer resistance protein (BCRP/ABCG2) -mediated drug resistance

Call No. (NDL)
UT51-2005-E882
Bibliographic ID of National Diet Library
000007852322
Material type
博士論文
Author
Yoichi Nakamura [著]
Publisher
[Yoichi Nakamura]
Publication date
[2005]
Material Format
Paper
Capacity, size, etc.
1冊
Name of awarding university/degree
長崎大学,博士 (医学)
View All

Notes on use

Note (General):

博士論文

Search by Bookstore

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Paper

Material Type
博士論文
Author/Editor
Yoichi Nakamura [著]
Author Heading
中村, 洋一 ナカムラ, ヨウイチ
Publication, Distribution, etc.
Publication Date
[2005]
Publication Date (W3CDTF)
2005
Extent
1冊
Alternative Title
ゲフィチニブ('Iressa',ZD1839)は、Breast Cancer Resistance Protein(BCRP/ABCG2)を介した腫瘍細胞の薬剤耐性を克服しうる ゲフィチニブ 'Iressa' ZD1839 ワ Breast Cancer Resistance Protein BCRP ABCG2 オ カイシタ シュヨウ サイボウ ノ ヤクザイ タイセイ オ コクフクシウル
Degree grantor/type
長崎大学